home / stock / pfe / pfe articles


PFE Articles, Pfizer Inc. - From 06/13/24

Stock Information

Company Name: Pfizer Inc.
Stock Symbol: PFE
Market: NYSE
Website: pfizer.com

Menu

PFE PFE Quote PFE Short PFE News PFE Articles PFE Message Board
Get PFE Alerts

News, Short Squeeze, Breakout and More Instantly...

Pfizer Phase III DMD Gene Therapy Study Misses Goal | Benzinga

Pfizer (NYSE: PFE) announced that a phase III study on its mini-dystrophin gene therapy fordadistrogene movaparvovec for treating Duchenne muscular...

What's Going On With Pfizer On Thursday? Pharma Giant's Shares Tick Lower | Benzinga

Pfizer Inc. (NYSE:PFE) shares are ticking lower after the company disclosed disappointing results from its Phase 3 CIFFREO study, evaluating the in...

Moderna Submits Updated COVID-19 Jab to FDA for Review | Benzinga

Moderna, Inc. (NASDAQ: MRNA) announced that it has submitted an application to the FDA seeking approval of its Spikevax 2024-2025 formula, tar...

Moderna Seeks FDA Approval For Updated COVID-19 Shot For Upcoming Season | Benzinga

On Friday, Moderna Inc. (NASDAQ:MRNA) announced that it has submitted an FDA application for review of its Spikevax 2024-2025 formula, which target...

Halozyme's ENHANZE Product Gets New Patent Grant in EU | Benzinga

Halozyme Therapeutics (NASDAQ: HALO) announced that it has been granted a new patent in the EU that covers the ENHANZE rHuPH20 product, which ...

What's Going On With Novavax Stock? | Benzinga

Novavax, Inc. (NASDAQ:NVAX) shares are trading higher Wednesday, and the stock is up by more than 300% over the past month. Here's a look at w...

Alphabet, Ventas, ASML And A Pharmaceutical Giant On CNBC's 'Final Trades' | Benzinga

Jim Lebenthal of Cerity Partners named Alphabet Inc. (NASDAQ:GOOG) (NASDAQ:GOOGL) as his final trade on CNBC's “Halftime Report Final Tr...

Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon | Benzinga

On Friday, Pfizer Inc (NYSE: PFE) revealed its drug for an advanced form of lung cancer showed promising long-term results in a late-stage tri...

Pfizer Highlights 'Unprecedented' 5 Year Data From Cancer Drug In Rare Form Of Advanced Lung Cancer | Benzinga

On Friday, Pfizer Inc (NYSE:PFE) released longer-term follow-up results from the Phase 3 CROWN trial evaluating Lorbrena (lorlatinib) available in ...

How To Earn $500 A Month From Pfizer Stock | Benzinga

Shares of Pfizer Inc. (NYSE:PFE) closed higher during Thursday's session, with the company's stock adding around 10% over the past month....

Previous 10 Next 10